Abstract
Purpose
To evaluate the efficacy of magnetic-activated cell sorting (MACS) or testicular sperm aspiration (TESA) to improve reproductive outcomes in cases with elevated sperm DNA fragmentation undergoing assisted reproduction.
Methods
This randomized controlled trial included couples with failed IVF cycles and sperm DNA fragmentation > 30%. Sperm DNA fragmentation was assessed using the sperm chromatin structure assay (SCSA) method. Participants were randomly assigned to either the MACS or TESA group. Testicular sperm retrieval was performed for the TESA group, while MACS involved sperm selection using magnetic beads. Extended blastocyst culture, freeze all policy of blastocysts by vitrification, and frozen embryo transfer were undertaken as per clinic’s standard operating protocols. Blastocyst formation rate, implantation rate, miscarriage rate, multiple pregnancy rate, and live birth rate were analyzed and compared between MACS and TESA groups.
Results
There were no significant differences in female age, male age, or sperm DNA fragmentation index (DFI) between the MACS and TESA groups. The blastocyst conversion rate was slightly higher in the TESA group (39%) compared to the MACS group (32%). However, the MACS group had a higher implantation rate (50%) than the TESA group (35%). Miscarriage rates, multiple pregnancy rates, and live birth rates did not show statistically significant differences between the groups. A chi-squared test was conducted to compare categorical variables, and t-tests were done to compare continuous variables.
Conclusion
In cases with raised sperm DNA fragmentation, sperm selection by MACS or TESA seems to offer comparable reproductive outcomes. There seems no superiority of one intervention over the other in cases with raised sperm DNA fragmentation undergoing assisted reproduction. Both interventions seem to be beneficial for couples seeking assisted reproduction with raised sperm DNA fragmentation.
Similar content being viewed by others
Data availability
The data that supports the findings of this research are not publicly available due to institutional restrictions. However, the datasets/tables/figures generated during this study or support the findings of the current study are available from the corresponding author upon reasonable request.
References
Infertility [Internet]. World Health Organization. Available from: https://www.who.int/news-room/fact-sheets/detail/infertility. Accessed 23 June 2023.
Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10.
1 in 6 people globally affected by infertility: Who [Internet]. World Health Organization. Available from: https://www.who.int/news/item/04-04-2023-1-in-6-people-globally-affected-by-infertility. Accessed 23 June 2023.
Ombelet W. Global access to infertility care in develo** countries: a case of human rights, equity and social justice. Facts Views Vis Obgyn. 2011;3(4):257–66.
Jain M, Singh M. Assisted Reproductive Technology (ART) Techniques. [Updated 2022 Nov 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK576409/. Accessed 7 June 2023.
Merchant R, Gandhi G, Allahbadia GN. In vitro fertilization/intracytoplasmic sperm injection for male infertility. Indian J Urol. 2011;27(1):121–32.
Agarwal A, Majzoub A, Baskaran S, Panner Selvam MK, Cho CL, Henkel R, et al. Sperm DNA fragmentation: a new guideline for clinicians. World J Mens Health. 2020;38(4):412–71.
González-Marín C, Gosálvez J, Roy R. Types, causes, detection and repair of DNA fragmentation in animal and human sperm cells. Int J Mol Sci. 2012;13(11):14026–52.
Hozyen M, Hasanen E, Elqusi K, ElTanbouly S, Gamal S, Hussin AG, et al. Reproductive outcomes of different sperm selection techniques for ICSI patients with abnormal sperm DNA fragmentation: a randomized controlled trial. Reprod Sci. 2022;29(1):220–8.
Pacheco A, Blanco A, Bronet F, Cruz M, García-Fernández J, García-Velasco JA. Magnetic-activated cell sorting (MACS): a useful sperm-selection technique in cases of high levels of sperm DNA fragmentation. J Clin Med. 2020;9(12):3976.
Gil M, Sar-Shalom V, Melendez Sivira Y, Carreras R, Checa MA. Sperm selection using magnetic activated cell sorting (MACS) in assisted reproduction: a systematic review and meta-analysis. J Assist Reprod Genet. 2013;30(4):479–85.
Shah R. Surgical sperm retrieval: techniques and their indications. Indian J Urol. 2011;27(1):102–9.
Esteves S, Roque M, Garrido N. Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis. Asian J Androl. 2018;20(1):1.
Zini A, Alharbi M, Hamouche F, Phillips S, Kadoch J. Use of testicular sperm in couples with SCSA-defined high sperm DNA fragmentation and failed intracytoplasmic sperm injection using ejaculated sperm. Asian J Androl. 2019;22(4):348–53.
Li F, Duan X, Li M, Ma X. Sperm DNA fragmentation index affect pregnancy outcomes and offspring safety in assisted reproductive technology. Scientific Reports. 2024;14(1):356. https://www.nature.com/articles/s41598-023-45091-6. Accessed 3 Jan 2024.
Esteves SC, Zini A, Coward RM, Evenson DP, Gosálvez J, Lewis SEM, Sharma R, Humaidan P. Sperm DNA fragmentation testing: summary evidence and clinical practice recommendations. Andrologia. 2021;53(2):e13874.
Mantravadi K, Gedela DR, Karunakaran S. Raised sperm DNA fragmentation–randomized controlled trial of MACS vs TESA to optimise reproductive outcomes. Fertil Steril. 2020;114(3):e370.
Makhseed MA, Al Salem MH, Ahmed MA. Percutaneous testicular sperm aspiration and intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia: an easy alternative to TESE and MESA. Urol Int. 2002;68(2):86–90.
Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155–8.
Javed M, L. Tan S. Advances in male infertility treatment through assisted reproductive technology [Internet]. Recent Advances in Male Reproductive System. IntechOpen; 2023. Available from: https://doi.org/10.5772/intechopen.1002435
Esteves SC, Sánchez-Martín F, Sánchez-Martín P, Schneider DT, Gosálvez J. Comparison of reproductive outcome in oligozoospermic men with high sperm DNA fragmentation undergoing intracytoplasmic sperm injection with ejaculated and testicular sperm. Fertil Steril. 2015;104(6):1398–405.
Greco E, Scarselli F, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, et al. Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Human Reproduction. 2005;20(1):226–30. https://academic.oup.com/humrep/article/20/1/226/671628. Accessed 11 Nov 2004.
Bradley CK, McArthur SJ, Gee AJ, Weiss KA, Schmidt U, Toogood L. Intervention improves assisted conception intracytoplasmic sperm injection outcomes for patients with high levels of sperm DNA fragmentation: a retrospective analysis. Andrology. 2016;4(5):903–10.
Fedder J, Loft A, Parner ET, Rasmussen S, Pinborg A. Neonatal outcome and congenital malformations in children born after ICSI with testicular or epididymal sperm: a controlled national cohort study. Human Reprod. 2013;28(1):230–40.
** L, Li Z, Gu L, Huang B. Neonatal outcome of children born after ICSI with epididymal or testicular sperm: a 10-year study in China. Sci Rep. 2020;10(1):5145. https://www.nature.com/articles/s41598-020-62102-y. Accessed 20 Mar 2020.
Stimpfel M, Verdenik I, Zorn B, Virant-Klun I. Magnetic-activated cell sorting of non-apoptotic spermatozoa improves the quality of embryos according to female age: a prospective sibling oocyte study. J Assist Reprod Genet. 2018;35(9):1665–74.
Ziarati N, Tavalaee M, Bahadorani M, Nasr Esfahani MH. Clinical outcomes of magnetic activated sperm sorting in infertile men candidate for ICSI. Hum Fertil (Camb). 2019;22(2):118–25.
Tournaye H, Verheyen G, Albano C, Camus M, Van Landuyt L, Devroey P, et al. Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. Fertil Steril. 2002;78(5):1030–7.
Horta F, Crosby J, Mackenna A, Huidobro C. Male factor infertility outcomes using magnetic activated cell sorting in intra citoplasmatic sperm injection cycles. Androl Open Access. 2016;5:1–6.
Javed A, Ramaiah MK, Talkad MS. ICSI using fresh and frozen PESA-TESA spermatozoa to examine assisted reproductive outcome retrospectively. Obstet Gynecol Sci. 2019;62(6):429–37.
Mei J, Chen LJ, Zhu XX, Yu W, Gao QQ, Sun HX, et al. Magnetic-activated cell sorting of non-apoptotic spermatozoa with a high DNA fragmentation index improves the live birth rate and decreases transfer cycles of IVF/ICSI. Asian J Androl. 2022;24(4):367–72.
Garrido N, Juliá María Gil. The use of non-apoptotic sperm selected by magnetic activated cell sorting (MACS) to enhance reproductive outcomes: what the evidence says. Biology. 2024;13(1):30.
Mantravadi Krishna Chaitanya, Rao Durga Gedela, Rupa Sree Y. Does testicular sperm alter reproductive and perinatal outcomes in assisted reproductive technology cycles? 10 years’ experience in an Indian clinic. J Hum Reprod Sci. 2022;15(4):388–8.
Popal W, Nagy ZP. Laboratory processing and intracytoplasmic sperm injection using epididymal and testicular spermatozoa: what can be done to improve outcomes? Clinics. 2013;68(Suppl 1):125–30.
Acknowledgements
The authors would like to thank Dr. Mehul R. Chorawala and Ms. Sakshi Srivastava (Intas Pharmaceuticals Limited, Ahmedabad, India) for providing scientific writing assistance and follow-up with the editorial office of the journal. The authors are also grateful to Dr. Vishal Dave of Intas Pharmaceuticals Limited, Ahmedabad, India for the critical review of the manuscript at various stages.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent to participate
All participants provided a written informed consent form to participate in the study.
Consent for publication
Consent for publication was obtained from all authors, the participants, or legally authorized representatives involved in this study.
Competing interest
The authors declare that they have no financial or non-financial or any other conflicts of interest related to this study. This study has no commercial interest in MACS technology and we have not received any funding or support from MACS technology company. The reason for choosing MACS is purely academic and scientific and not intended for any marketing or commercial purpose.
Additional information
The authors declare that this manuscript has not been submitted elsewhere for consideration and has not been published previously. All authors have read and approved the manuscript for submission.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mantravadi, K.C., Rao, D. In cases with raised sperm DNA fragmentation, can sperm selection by magnetic-activated cell sorting or testicular sperm aspiration help improve reproductive outcomes?. J Assist Reprod Genet (2024). https://doi.org/10.1007/s10815-024-03128-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10815-024-03128-3